Abstract

HomeRadiologyVol. 297, No. 1 Previous ErratumFree AccessContrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane for the Diagnosis of Hepatocellular Carcinoma in Individuals with High RiskHyo-Jin Kang, Jeong Min Lee, Jeong Hee Yoon, Kyoungbun Lee, Haeryoung Kim, Joon Koo HanHyo-Jin Kang, Jeong Min Lee, Jeong Hee Yoon, Kyoungbun Lee, Haeryoung Kim, Joon Koo HanHyo-Jin KangJeong Min LeeJeong Hee YoonKyoungbun LeeHaeryoung KimJoon Koo HanPublished Online:Aug 25 2020https://doi.org/10.1148/radiol.2020209017MoreSectionsPDF ToolsImage ViewerAdd to favoritesCiteTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinked In Originally published online:https://doi.org/10.1148/radiol.2020200115Erratum in:DOI:10.1148/radiol.2020209017A paragraph was missing in the initial online version. The following paragraph should be in the Materials and Methods section after the Contrast-enhanced US heading:Real-time contrast-enhanced US was performed by one of two board-certified radiologists (J.M.L. and H.J.K., with 24 and 8 years of experience with abdominal US and 11 and 4 years of experience with contrast-enhanced US, respectively) by using a contrast-specific US platform (RS80A [n = 24] or RS85A [n = 22], respectively [Samsung Medison, Seoul, Korea] or LOGIQ E9 [n = 8; GE Healthcare, Berlin, Germany]) with a convex probe. SHF (SonoVue; Bracco, Milan, Italy) and PFB (Sonazoid; GE Healthcare, Milwaukee, Wis) were used as contrast agents (Table E1 [online]). Both contrast agents were prepared according to the manufacturer’s recommendations. After the SHF US examination, B-mode scanning and high-mechanical-index impulses were performed to ensure microbubble degradation. PFB-enhanced US was performed with at least 30-minute intervals. The detailed process is described in Appendix E2 [online]. Different US parameters were used, depending on the contrast agent and US machines (Table E2 [online]): mechanical index of 0.08–0.14 for SHF and 0.19– 0.22 for PFB. For indistinguishable lesions, real-time US images were fused with CT/MRI scans for accurate examination (n = 18, 31%).Article HistoryPublished online: Aug 25 2020Published in print: Oct 2020 FiguresReferencesRelatedDetailsCited ByContrast‐Enhanced Ultrasound With SonoVue and Sonazoid for the Diagnosis of Colorectal Liver Metastasis After ChemotherapyLiqiSun, ShanshanYin, BaocaiXing, ZhongwuLi, ZhihuiFan, KunYan2023 | Journal of Ultrasound in Medicine, Vol. 42, No. 2Prospective assessment of diagnostic efficacy and safety of SonazoidTM and SonoVue® ultrasound contrast agents in patients with focal liver lesionsKeLv, HongyanZhai, YuxinJiang, PingLiang, Hui-XiongXu, LianfangDu, Yi-HongChou, XiaoyanXie, YuKunLuo, Young JoonLee, Jae YoungLee, BingHu, BaomingLuo, YiWang, YingLuan, ChristinaKalli, KunChen, WenpingWang, Ja-DerLiang2021 | Abdominal Radiology, Vol. 46, No. 10Accompanying This ArticleContrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane for the Diagnosis of Hepatocellular Carcinoma in Individuals with High RiskAug 4 2020RadiologyRecommended Articles Contrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane for the Diagnosis of Hepatocellular Carcinoma in Individuals with High RiskRadiology2020Volume: 297Issue: 1pp. 108-116CT/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-AnalysisRadiology2021Volume: 302Issue: 2pp. 326-335Diagnostic Performance of Gadoxetic Acid–enhanced Liver MR Imaging versus Multidetector CT in the Detection of Dysplastic Nodules and Early Hepatocellular CarcinomaRadiology2017Volume: 285Issue: 1pp. 134-146Gadoxetate-enhanced Abbreviated MRI for Hepatocellular Carcinoma Surveillance: Preliminary ExperienceRadiology: Imaging Cancer2019Volume: 1Issue: 2Integration of Contrast-enhanced US into a Multimodality Approach to Imaging of Nodules in a Cirrhotic Liver: How I Do ItRadiology2017Volume: 282Issue: 2pp. 317-331See More RSNA Education Exhibits Diagnostic and Procedural Intraoperative Ultrasound: Technique, Tips, and Tricks for Optimizing ResultsDigital Posters2019Hepatocellular Carcinoma (HCC) in Evolution: Correlation with CEUS LI-RADSDigital Posters2020Keys to Starting LI-RADS in Your Practice: Tips from the Society of Abdominal Radiology-HCC Diagnosis Disease Focused Panel  Digital Posters2020 RSNA Case Collection Hepatic AdenomatosisRSNA Case Collection2021LI-RADS 5RSNA Case Collection2022TI-RADS 5 NoduleRSNA Case Collection2022 Vol. 297, No. 1 Metrics Altmetric Score PDF download

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.